To include your compound in the COVID-19 Resource Center, submit it here.

Management tracks: Abeona, INKEF, Incyte

Abeona Therapeutics Inc. (NASDAQ:ABEO) terminated Carsten Thiel for personal misconduct towards colleagues, less than eight months after hiring him as CEO. The rare genetic disease company named Head of R&D and CMO João Siffert interim CEO while a permanent successor is sought.

Prior to Abeona, Thiel served as CCO of Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) until his departure in 2017, one of several from that

Read the full 636 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE